Caffeine Neuroprotective Mechanism Against β-Amyloid Neurotoxicity in SHSY5Y Cell Line: Involvement of Adenosine, Ryanodine, and N-Methyl-D-Aspartate Receptors

Mojtaba Keshavarz ¹ * , Majid Reza Farrokhi ¹, Atena Amiri ¹

Cited by CrossRef: 7

1- Gupta S, Dasmahapatra A. Caffeine destabilizes preformed Aβ protofilaments: insights from all atom molecular dynamics simulations. Phys Chem Chem Phys. 2019;21(39):22067 [Crossref]

2- 蒋单. Advances in Sleep Induction by Adenosine Activation of A₁ and A_2A Receptors. ACM. 2023;13(02):2083 [Crossref]

3- Londzin P, Zamora M, Kąkol B, Taborek A, Folwarczna J. Potential of Caffeine in Alzheimer’s Disease—A Review of Experimental Studies. Nutrients. 2021;13(2):537 [Crossref]

4- Castillo C, Ballesteros-Yáñez I, León-Navarro D, Albasanz J, Martín M. Early Effects of the Soluble Amyloid β25-35 Peptide in Rat Cortical Neurons: Modulation of Signal Transduction Mediated by Adenosine and Group I Metabotropic Glutamate Receptors. IJMS. 2021;22(12):6577 [Crossref]

5- Gomaa A, Farghaly H, Ahmed A, El-Mokhtar M, Hemida F. Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia. European Journal of Pharmacology. 2022;921:174873 [Crossref]

6- Jawad M, Uthirapathy S, Altalbawy F, Oghenemaro E, Rizaev J, Lal M, Eldesoqui M, Sharma N, Pramanik A, AL-Hamairy A. Examining the role of antioxidant supplementation in mitigating oxidative stress markers in Alzheimer’s disease: a comprehensive review. Inflammopharmacol. 2024; [Crossref]

7- Pritam P, Deka R, Bhardwaj A, Srivastava R, Kumar D, Jha A, Jha N, Villa C, Jha S. Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects. Biology. 2022;11(2):212 [Crossref]

8- Badshah H, Ikram M, Ali W, Ahmad S, Hahm J, Kim M. Caffeine May Abrogate LPS-Induced Oxidative Stress and Neuroinflammation by Regulating Nrf2/TLR4 in Adult Mouse Brains. Biomolecules. 2019;9(11):719 [Crossref]